| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/06/2000 | WO2000018352A3 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000015770A3 Human serine/threonine protein kinases |
| 07/06/2000 | WO2000014222A3 Gabab receptor subtypes gabab-r1c and gabab-r2 and heterodimers thereof |
| 07/06/2000 | WO2000011028A3 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 07/06/2000 | WO1999063087A9 G-protein coupled receptor, named 2871 receptor |
| 07/06/2000 | WO1999052514A3 Pharmaceutical composition and combination preparation for immunosuppressive therapy |
| 07/06/2000 | CA2358067A1 (2-imidazolin-2-ylamino) quinoxaline derivatives for the treatment of pain |
| 07/06/2000 | CA2357765A1 Liposomic niflumic acid - new transdermal anti-inflammatory medicine |
| 07/06/2000 | CA2356986A1 Compounds and methods for modulation of estrogen receptors |
| 07/06/2000 | CA2356671A1 Protease inhibitors |
| 07/06/2000 | CA2356661A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | CA2356622A1 Compounds which affect mrna stability and uses therefor |
| 07/06/2000 | CA2356548A1 Human brainiac-5 |
| 07/06/2000 | CA2354052A1 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | CA2352896A1 Pyrimidine compounds |
| 07/06/2000 | CA2351539A1 Method for preparing (r)- (+) -3 {1- ¬2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl|- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/05/2000 | EP1015588A1 Cell growth regulator |
| 07/05/2000 | EP1015585A2 Tie ligand homologues |
| 07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
| 07/05/2000 | EP1015493A1 Novel epithelial tissue targeting agent |
| 07/05/2000 | EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 07/05/2000 | EP1015455A1 Pyrrolopyrrolone derivatives |
| 07/05/2000 | EP1015450A1 Novel pyridazine compounds |
| 07/05/2000 | EP1015438A1 Protease inhibitors |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/05/2000 | EP1015431A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 07/05/2000 | EP1015021A2 Agents for combating bacterial meningitis |
| 07/05/2000 | EP1015006A2 Cocoa extract compounds and methods for making and using the same |
| 07/05/2000 | EP1015003A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |
| 07/05/2000 | EP1014972A1 Method of treatment and pharmaceutical composion |
| 07/05/2000 | EP1014942A1 Non-steroidal antiinflammatory drug formulations for topical application to the skin |
| 07/05/2000 | EP1014886A1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
| 07/05/2000 | EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/05/2000 | EP0876392B1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
| 07/05/2000 | EP0788490B1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 07/05/2000 | EP0734381B1 Morpholine tachykinin receptor antagonists |
| 07/05/2000 | EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications |
| 07/05/2000 | EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists |
| 07/05/2000 | EP0570414B1 Naphthoquinone derivatives for the treatment of chronic inflammation |
| 07/05/2000 | CN1259132A Compounds |
| 07/05/2000 | CN1259131A Compounds |
| 07/05/2000 | CN1259048A Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 07/05/2000 | CN1258675A Process and intermediate for producing 5-lipoxidase inhibitor |
| 07/05/2000 | CN1258531A Wind evil-dispelling, meridian passage-dredging and pus-drawing out medicine powder |
| 07/05/2000 | CN1258523A Wound healing oil and its preparation |
| 07/05/2000 | CN1258514A Blood stasis removing analgesic plaster and its preparation |
| 07/05/2000 | CN1258450A Natural plant disinfectant and its preparation |
| 07/05/2000 | CN1054065C Rodgersflower rhizome extractive and medicine for relieving inflammation and pain with it as active constituent |
| 07/05/2000 | CA2293928A1 A novel substituted alkyltetraamine derivative |
| 07/04/2000 | US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer |
| 07/04/2000 | US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes |
| 07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
| 07/04/2000 | US6083996 Topical compositions for NSAI drug delivery |
| 07/04/2000 | US6083974 Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them |
| 07/04/2000 | US6083971 Certain oxopyrolo-pyrrole derivatives having thrombin inhibiting activity |
| 07/04/2000 | US6083959 Quinoline derivatives, processes for their preparation and their use as medicaments |
| 07/04/2000 | US6083952 Compounds |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 07/04/2000 | US6083918 Use of collagen for the treatment of degenerative articular processes |
| 07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
| 07/04/2000 | US6083536 Super-critical lipid extract from mussels having anti-inflammatory activity |
| 07/04/2000 | US6083521 Drugs and polyethylene carbonates |
| 07/04/2000 | US6083515 Treating inflammation, pain, gastrointestinal lesions or fever in an animal in need thereof with reduction of the gastrointestinal toxicity or renal toxicity of the nonsteroidal antiinflammatory drug |
| 07/04/2000 | CA2025212C (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 07/04/2000 | CA1341044C Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use |
| 06/29/2000 | WO2000037944A1 Kidney disease detection and treatment |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037504A2 Human monoclonal antibodies to ctla-4 |
| 06/29/2000 | WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
| 06/29/2000 | WO2000037472A2 Substituted pirroloindoles |
| 06/29/2000 | WO2000037462A1 Non-peptide nk1 receptors antagonists |
| 06/29/2000 | WO2000037451A1 Il-5 inhibiting 6-azauracil derivatives |
| 06/29/2000 | WO2000037444A1 Compounds useful in the treatment of inflammatory diseases |
| 06/29/2000 | WO2000037441A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 06/29/2000 | WO2000037358A1 NOVEL sPLA2 INHIBITORS |
| 06/29/2000 | WO2000037112A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | WO2000037089A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |
| 06/29/2000 | WO2000037088A1 Use of etherlysophospholipids as antiinflammatory agents |
| 06/29/2000 | WO2000037081A1 Novel formulation |
| 06/29/2000 | WO2000037073A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome |
| 06/29/2000 | WO2000037059A2 Compositions and methods to inactivate n-type calcium channels |
| 06/29/2000 | WO2000037056A2 Composition and method for treating glaucoma |
| 06/29/2000 | WO2000037054A1 A pharmaceutical mixture comprising a profen |
| 06/29/2000 | WO2000037053A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 06/29/2000 | WO2000037044A1 Soft and chewy cough and cold relief composition |
| 06/29/2000 | WO2000037037A2 Composition for treatment of burns |
| 06/29/2000 | WO2000037025A2 Antibodies to truncated vegf-d and uses thereof |
| 06/29/2000 | WO2000014262A3 Methylation of plasmid vectors |
| 06/29/2000 | WO2000012497A3 Quinazoline derivatives as medicaments |
| 06/29/2000 | WO2000012113A3 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions |
| 06/29/2000 | WO2000011926A3 Method for the preparation of citalopram |
| 06/29/2000 | WO2000009073A3 Blood-brain barrier therapeutics |
| 06/29/2000 | WO2000000610A3 Human signal peptide-containing proteins |
| 06/29/2000 | WO2000000594A3 Human transferases |
| 06/29/2000 | CA2356736A1 Use of etherlysophospholipids as antiinflammatory agents |